99 / 246
97
BUSINESS SECTORS
Pharmaceuticals, Health Supplements and Cosmetics
Simpor Pharma Sdn Bhd
A pioneering contract manufacturer in
Brunei Darussalam, Simpor Pharma Sdn Bhd
aims to become the hub for exporting Halal
pharmaceutical products and health supplements
in the global market.
Simpor Pharma offers comprehensive contract
manufacturing services for branded nutraceutical
and pharmaceutical companies to meet the
demands of this fast-growing market. This is also
opening great investment opportunities for the
Sultanate while providing Halal pharmaceutical
products to 1.9 billion Muslims across the world.
Certified by strict internationally recognised
standards, Simpor is a global integrated contract
manufacturer to provide the nutraceutical and
pharmaceutical industry with a wide array of
innovative and tailor-made solutions.
Simpor Pharma Sdn Bhd in Brunei complies with
the worldwide current GMP standard for phar-
maceutical products and health supplements,
including softgels, hard shell capsules, tablets,
powder and oral liquid.
Sengenics
Sengenics is a genomics and proteomics-based
research and diagnostics company that opened
its new DNA sequencing and microarray facility
at Universiti Brunei Darussalam (UBD) in 2015.
The partnership between UBD and Sengenics
grew from a research collaboration agreement,
which began in July 2014.
The Brunei-based facility focusses on two core
activities. Firstly, the company offers commercial
services leveraging its patented autoantibody
profiling platform and the clinical genomics
diagnosis pipeline. Second, in collaboration
with UBD and supported by the Brunei
Economic Development Board (BEDB) through
the Brunei Research Incentive Scheme (BRISc),
Sengenics has embarked upon two novel
Halal meat and food related research and
commercialisation projects.
In April 2017, the new Sengenics Immunome
Production Facility was opened in UBD.
The new facility offers protein cloning and
expression services using the patented BCCP
(biotin carboxyl carrier protein) folding marker
technology. This supports the commercially
available flagship technology that is offered
by Sengenics, the Immunome Protein Array
Platform, which is used for a variety of
pharmaceutical screening and drug discovery
applications.